The South Pacific nation of Fiji, long celebrated as a tropical honeymoon destination, is now grappling with a public health crisis that has thrust it into an unwanted global spotlight. In mid-September, the government declared a national emergency in response to an alarming surge in HIV infections, a wave that health experts say is being propelled by a parallel epidemic of crystal methamphetamine addiction.
According to figures released by the United Nations Programme on HIV/AIDS, new HIV cases in Fiji climbed twelvefold between 2010 and 2025. Current estimates place the number of people living with the virus at more than 9,000. The country's health minister has stated that roughly one in every 60 adults in Fiji is now HIV-positive, a prevalence rate that would be extraordinary for any nation, let alone one with a population of under a million.
Jason Mitchell, a public health specialist who leads Fiji's national HIV response, used the AIDS 2026 conference in Rio de Janeiro in July to describe the situation as the fastest-growing HIV epidemic anywhere in the world. He noted that two-thirds of all cases are concentrated among people between the ages of 20 and 34 — the cohort that typically forms the backbone of a country's workforce and civic life.
"Our young, active, productive population is currently being infected with HIV, and unless we find solutions quickly, this will continue to get worse," Mitchell warned at the conference, underscoring the urgency of the moment.
What makes Fiji's outbreak particularly difficult to combat is its close entanglement with drug use. Crystal meth has circulated within the islands for years, largely because Fiji sits on a well-established trafficking route that moves narcotics from South America toward Australia and New Zealand. But experts say consumption within Fiji itself has skyrocketed since the COVID-19 pandemic, driven by a combination of rising unemployment and increasingly easy access to the drug.
The result has been a shift in how HIV is spreading. Whereas the virus was once transmitted primarily through sexual contact in Fiji, a growing share of new infections is now linked to needle sharing among people who inject meth. This mode of transmission is especially efficient at spreading bloodborne pathogens and is notoriously difficult to interrupt once it takes hold in a community.
The human cost of this dual crisis is visible in the stories of those on the front lines. Mark Lal, a 25-year-old activist from the capital, Suva, has turned his personal losses into a mission. As the founder of Living Positive Fiji, an organization that supports people living with HIV, and a reconciliation officer for the Fiji Truth and Reconciliation Commission, Lal speaks with the authority of someone who has witnessed the epidemic up close.
"The majority of my friends, they got HIV through crystal meth," Lal said. "Two of my best friends passed away."
Lal's account reflects a broader pattern across Fiji's younger generation, in which experimentation with meth — often starting with smoking and progressing to injection — creates a direct pathway to HIV infection. Public health officials say the stigma surrounding both drug use and HIV compounds the problem, discouraging people from seeking testing or treatment until the virus has already advanced.
The national emergency declaration, issued in mid-September, grants the government expanded powers to mobilize resources, coordinate across agencies, and accelerate its response. It also signals to international partners and donors that Fiji regards the outbreak as a crisis requiring sustained outside support, not merely a domestic health matter.
Fiji's circumstances illustrate a troubling intersection of geography, economics, and public health. As a transit hub for the drug trade, the country faces a supply-side pressure that is largely beyond its control. And as a developing island economy still recovering from the disruptions of the pandemic, it lacks the resources to simultaneously expand HIV testing, treatment, and prevention while also building out addiction and harm-reduction services.
The stakes extend well beyond Fiji's borders. Because the virus does not respect national boundaries and because drug trafficking routes connect the Pacific to larger markets, an unchecked epidemic in one island nation poses risks for regional health security. Experts warn that without decisive intervention, Fiji could become a reservoir of infection that complicates HIV control efforts across the South Pacific.
For now, the government's emergency declaration represents a first step. Whether it translates into meaningful reductions in new infections will depend on how quickly Fiji can scale up needle-exchange programs, expand access to antiretroviral therapy, and address the social conditions — unemployment, stigma, and limited mental health support — that have made its young people so vulnerable. As Mitchell's remarks made clear, the window for action is narrowing, and the country's most productive generation is paying the price.
(0)